These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 14654919)

  • 1. Intratumoral injection of arsenic to enhance antitumor efficacy in human esophageal carcinoma cell xenografts.
    Shen ZY; Zhang Y; Chen JY; Chen MH; Shen J; Luo WH; Zeng Y
    Oncol Rep; 2004 Jan; 11(1):155-9. PubMed ID: 14654919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The inhibition of growth and angiogenesis in heterotransplanted esophageal carcinoma via intratumoral injection of arsenic trioxide.
    Shen ZY; Shen J; Chen MH; Wu XY; Wu MH; Zeng Y
    Oncol Rep; 2003; 10(6):1869-74. PubMed ID: 14534710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Arsenic trioxide (As2O3) sensitivity of carcinoma cell lines and cancer cells from patients with carcinomatosis peritonei.
    Moon Y; Park G; Kim Y; Kim M; Lim J; Pai SH; Lee EJ; Kang CS; Han K
    Ann Clin Lab Sci; 2004; 34(3):271-6. PubMed ID: 15487701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition on LS-174T cell growth and activity of telomerase in vitro and in vivo by arsenic trioxide.
    Wang X; Wang G; Dong D; Fu S; Yang B
    Exp Toxicol Pathol; 2008 Sep; 60(6):481-8. PubMed ID: 18606528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Arsenic trioxide is effective in the treatment of multiple myeloma in SCID mice.
    Rousselot P; Larghero J; Labaume S; Poupon J; Chopin M; Dosquet C; Marolleau JP; Janin A; Brouet JC; Fermand JP
    Eur J Haematol; 2004 Mar; 72(3):166-71. PubMed ID: 14962234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Arsenic trioxide: safety issues and their management.
    Au WY; Kwong YL
    Acta Pharmacol Sin; 2008 Mar; 29(3):296-304. PubMed ID: 18298894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased cure rate of glioblastoma using concurrent therapy with radiotherapy and arsenic trioxide.
    Ning S; Knox SJ
    Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):197-203. PubMed ID: 15337556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Construction of a BALB/c-Nu Mouse Model of Invasive Bladder Carcinoma and Preliminary Studies on the Treatment of Bladder Tumors through Internal Iliac Arterial Infusion of Albumin-Bound Arsenic Trioxide (As2O3).
    Li Y; Yu G; Li Q; Wang W; Shen X; Liu H; Liu R
    PLoS One; 2015; 10(4):e0124959. PubMed ID: 25915411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synergistic therapeutic effect of arsenic trioxide and radiotherapy in BALB/C nude mice bearing nasopharyngeal carcinoma xenografts.
    Xie LX; Lin XH; Li DR; Chen JY; Hong CQ; Du CW
    Exp Oncol; 2007 Mar; 29(1):45-8. PubMed ID: 17431388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergic effect of 3'-azido-3'-deoxythymidine and arsenic trioxide in suppressing hepatoma cells.
    Chen C; Zhang Y; Wang Y; Huang D; Xi Y; Qi Y
    Anticancer Drugs; 2011 Jun; 22(5):435-43. PubMed ID: 21502917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation of arsenic trioxide-loaded albuminutes immuno-nanospheres and its specific killing effect on bladder cancer cell in vitro.
    Zhou J; Zeng FQ; Li C; Tong QS; Gao X; Xie SS; Yu LZ
    Chin Med J (Engl); 2005 Jan; 118(1):50-5. PubMed ID: 15642226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Arsenic trioxide induces apoptosis of rat hepatocellular carcinoma cells in vivo.
    Zhang T; Wang SS; Hong L; Wang XL; Qi QH
    J Exp Clin Cancer Res; 2003 Mar; 22(1):61-8. PubMed ID: 12725324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differentiation of human nasopharyngeal carcinoma xenografts and repression of telomerase activity induced by arsenic trioxide.
    Du C; Li D; Lin Y; Wu M
    Natl Med J India; 2004; 17(2):67-70. PubMed ID: 15141597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Significance of intracellular arsenic trioxide for therapeutic response in acute promyelocytic leukemia.
    Sahu GR; Jena RK
    Am J Hematol; 2005 Feb; 78(2):113-6. PubMed ID: 15682419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antimyeloma effects of arsenic trioxide are enhanced by melphalan, bortezomib and ascorbic acid.
    Campbell RA; Sanchez E; Steinberg JA; Baritaki S; Gordon M; Wang C; Shalitin D; Chen H; Pang S; Bonavida B; Said J; Berenson JR
    Br J Haematol; 2007 Aug; 138(4):467-78. PubMed ID: 17587338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Study of arsenic trioxide-induced vascular shutdown and enhancement with radiation in solid tumor.
    Monzen H; Griffin RJ; Williams BW; Amano M; Ando S; Hasegawa T
    Radiat Med; 2004; 22(4):205-11. PubMed ID: 15468939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic availability of arsenic from oral arsenic-trioxide used to treat patients with hematological malignancies.
    Kumana CR; Au WY; Lee NS; Kou M; Mak RW; Lam CW; Kwong YL
    Eur J Clin Pharmacol; 2002 Nov; 58(8):521-6. PubMed ID: 12451429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tissue distribution of arsenic species in rabbits after single and multiple parenteral administration of arsenic trioxide: tissue accumulation and the reversibility after washout are tissue-selective.
    Lin CJ; Wu MH; Hsueh YM; Sun SS; Cheng AL
    Cancer Chemother Pharmacol; 2005 Feb; 55(2):170-8. PubMed ID: 15322825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Arsenic trioxide restores ERα expression in ERα-negative human breast cancer cells and its treatment efficacy in combination with tamoxifen in xenografts in nude mice].
    Zhang WJ; Xu DF; Fan QX; Wu XA; Wang F; Wang R; Wang LX
    Zhonghua Zhong Liu Za Zhi; 2012 Sep; 34(9):645-51. PubMed ID: 23159075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inter- and intratumoral disposition of platinum in solid tumors after administration of cisplatin.
    Zamboni WC; Gervais AC; Egorin MJ; Schellens JH; Hamburger DR; Delauter BJ; Grim A; Zuhowski EG; Joseph E; Pluim D; Potter DM; Eiseman JL
    Clin Cancer Res; 2002 Sep; 8(9):2992-9. PubMed ID: 12231546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.